Acadian Asset Management’s Universe Pharmaceuticals Inc UPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1
Closed 2352
2024
Q2
$0 Hold
1
﹤0.01% 1909
2024
Q1
$0 Sell
1
-10
-91% -$11.3K ﹤0.01% 1793
2023
Q4
$12K Hold
11
﹤0.01% 1616
2023
Q3
$5K Hold
11
﹤0.01% 1607
2023
Q2
$12K Hold
11
﹤0.01% 1673
2023
Q1
$21K Hold
11
﹤0.01% 1653
2022
Q4
$55K Buy
11
+7
+175% +$32.4K ﹤0.01% 1561
2022
Q3
$7K Hold
4
﹤0.01% 1642
2022
Q2
$8K Hold
4
﹤0.01% 1645
2022
Q1
$16K Hold
4
﹤0.01% 1585
2021
Q4
$21K Buy
+4
New +$30.7K ﹤0.01% 1608

Other funds holding UPC

Acadian Asset Management's UPC Position: Q3 2024 in Review

Acadian Asset Management sold out of Universe Pharmaceuticals Inc (UPC) in Q3 2024, closing a stake of 1 share.

Acadian Asset Management first reported a position in UPC in Q4 2021 and held it in 11 quarters. The position peaked at $55K in Q4 2022. 9 funds tracked by Wall St. Rank hold UPC as of Q3 2024.

  • Acadian Asset Management reported no remaining Universe Pharmaceuticals Inc position as of Q3 2024 after selling out during the quarter.
  • Acadian Asset Management sold 1 Universe Pharmaceuticals Inc share in Q3 2024.
  • Acadian Asset Management first reported a position in Universe Pharmaceuticals Inc in Q4 2021 and held it in 11 quarters.
  • Acadian Asset Management's Universe Pharmaceuticals Inc position peaked at $55K in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q3 2024.

Based on Acadian Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.